AVIR · Atea Pharmaceuticals, Inc.

$4.81 -0.06 (-1.23%) At close · Jul 22

Market Cap

$384.93M

80.03M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jean-Pierre Sommadossi	CEO	$703,490	—	$1,315,800	$962,368	$422,094	—	$3,403,752
Janet Hammond	Chief Medical Officer	$590,892	—	$459,000	$437,440	$265,902	$14,000	$1,767,234
Andrea Corcoran	CFO	$549,530	—	$442,170	$437,440	$247,288	$14,000	$1,690,428
Dr. Maria Arantxa Horga	Chief Medical Officer	$523,644	—	$425,034	$421,692	$209,458	$14,000	$1,593,827
John Vavricka	Chief Operations Officer	$443,169	—	$292,842	$290,460	$177,268	$14,000	$1,217,738

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jean-Pierre Sommadossi	CEO	$703,490	—	$1,788,800	$1,372,358	$337,675	—	$4,202,323
Janet Hammond	Chief Medical Officer	$573,682	—	$675,168	$689,855	$206,526	$13,800	$2,159,031
Andrea Corcoran	CFO	$533,524	—	$601,120	$612,660	$170,728	$13,800	$1,931,832
Dr. Maria Arantxa Horga	Chief Medical Officer	$508,392	—	$577,824	$590,604	$162,686	$13,800	$1,853,306
John Vavricka	Chief Operations Officer	$430,261	—	$398,112	$406,806	$137,684	$13,800	$1,386,663

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jean-Pierre Sommadossi	CEO	$683,000	—	$2,409,452	$2,474,763	$358,575	—	$5,925,790
Janet Hammond	Chief Medical Officer	$556,973	—	$650,052	$667,772	$219,300	$13,200	$2,107,297
Andrea Corcoran	CFO	$517,984	—	$616,253	$632,787	$181,300	$13,200	$1,961,524
Dr. Maria Arantxa Horga	Chief Medical Officer	$493,584	—	$576,898	$592,707	$172,800	$13,200	$1,849,189
Wayne Foster	Chief Accounting Officer	$420,163	—	$463,000	$475,524	$147,100	$13,200	$1,518,987
John Vavricka	Chief Operations Officer	$417,729	—	$463,000	$475,524	$146,205	$13,200	$1,515,658

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jean-Pierre Sommadossi	CEO	$650,000	—	$2,842,220	$1,937,306	$448,500	—	$5,878,026
Janet Hammond	Chief Medical Officer	$530,450	—	$321,300	$973,693	$274,508	$12,200	$2,112,151
Andrea Corcoran	CFO	$493,319	—	$299,880	$927,571	$226,927	$12,200	$1,959,897
Dr. Maria Arantxa Horga	Chief Medical Officer	$470,080	—	$278,460	$871,199	$216,237	$9,537	$1,845,513
John Vavricka	Chief Operations Officer	$397,838	—	$249,900	$691,835	$171,070	$12,200	$1,522,843

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jean-Pierre Sommadossi	CEO	$650,000	—	—	$33,123,392	$331,500	—	$34,104,892
Janet Hammond	Chief Medical Officer	$515,000	—	—	$8,283,435	$196,988	$11,600	$9,007,023
Andrea Corcoran	CFO	$478,950	—	—	$7,703,776	$162,842	$11,600	$8,357,169
Dr. Maria Arantxa Horga	Chief Medical Officer	$452,000	—	—	$7,530,396	$142,380	$11,600	$8,136,376
John Vavricka	Chief Operations Officer	$386,250	—	—	$6,070,896	$131,325	$10,944	$6,599,415

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Janet Hammond	Chief Medical Officer	$197,115	$431,203	—	$3,302,000	—	$100,000	$4,030,318
Jean-Pierre Sommadossi	CEO	$436,862	$466,125	—	$1,984,000	—	—	$2,886,987
Nathanial Brown	Former Chief Medical Officer	$197,500	$57,000	—	$2,257,286	—	$85,000	$2,596,784
Dr. Maria Arantxa Horga	Chief Medical Officer	$142,564	$225,000	—	$1,781,500	—	—	$2,149,064
Andrea Corcoran	CFO	$465,000	$279,000	—	$744,000	—	—	$1,488,000

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jean-Pierre Sommadossi	CEO	$400,000	$160,000	—	$251,080	—	—	$811,080
Andrea Corcoran	CFO	$290,000	$75,000	—	$75,324	—	—	$440,324

Key facts CIK 1593899 CUSIP 04683R106 13F (30d) 13 filings 13 filers Visit website Investor relations